Skip to content

Clinical trials

Phase 3 Sarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 3 Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20032
20041
20062
20073
20085
20103
20112
20141
20151
20161
20171
20182
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated6
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group8
Memorial Sloan Kettering Cancer Center3
Gynecologic Oncology Group2
University of South Florida2
Advenchen Laboratories, LLC1
Alaunos Therapeutics1
Alliance for Clinical Trials in Oncology1
Eisai Inc.1
Eli Lilly and Company1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma38
Leiomyosarcoma5
Liposarcoma5
Neuroectodermal Tumors, Primitive, Peripheral5
Neoplasms4
Rhabdomyosarcoma4
Sarcoma, Synovial4
Burkitt Lymphoma3
Fibrosarcoma3
Hemangiosarcoma3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.